{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:59:32Z","timestamp":1792202372752,"version":"4.4.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,27]]},"DOI":"10.1097\/qad.0b013e32835cae3b","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T07:43:17Z","timestamp":1353570197000},"page":"961-965","source":"Crossref","is-referenced-by-count":27,"title":["Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment"],"prefix":"10.1097","volume":"27","author":[{"given":"Mohammed","family":"Lamorde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Byakika-Kibwika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mayito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Nabukeera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairin","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warunee","family":"Hanpithakpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Back","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saye H.","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepta","family":"Merry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210130","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jac\/dkn330","article-title":"Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs.","volume":"62","author":"Sousa","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R4-12-20210130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00003088-200847020-00002","article-title":"Clinical pharmacology of artemisinin-based combination therapies.","volume":"47","author":"German","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"R6-12-20210130","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2125.1998.00830.x","article-title":"Population pharmacokinetics and therapeutic response of CGP 56697 (artemether benflumetol) in malaria patients.","volume":"46","author":"Ezzet","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"R7-12-20210130","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jac\/37.6.1111","article-title":"Inducing properties of rifampicin and rifabutin for selected enzyme activities of the cytochrome P-450 and UDP-glucuronosyltransferase superfamilies in female rat liver.","volume":"37","author":"Oesch","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"R8-12-20210130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.","volume":"37","author":"White","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"R9-12-20210130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4155\/bio.09.6","article-title":"A liquid chromatographic-tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma.","volume":"1","author":"Hanpithakpong","year":"2009","journal-title":"Bioanalysis"},{"key":"R10-12-20210130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jchromb.2005.06.022","article-title":"High throughput assay for the determination of lumefantrine in plasma.","volume":"822","author":"Annerberg","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R12-12-20210130","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/jac\/dks207","article-title":"Significant pharmacokinetic interactions between artemetherlumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.","volume":"67","author":"Byakika-Kibwika","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"R13-12-20210130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria.","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"R14-12-20210130","doi-asserted-by":"crossref","first-page":"d211","DOI":"10.1136\/bmj.d211","article-title":"WHO unveils plan to stop artemisinin resistance dead in its tracks.","volume":"342","author":"Zarocostas","year":"2011","journal-title":"BMJ"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201303270-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:17:51Z","timestamp":1618039071000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201303270-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,27]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32835cae3b","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,27]]}}}